ArticleFrontiers in pharmacology2021

Exploring the Appropriate Price of Semaglutide for Type 2 Diabetes Patients Based on Cost-Utility Analysis in China.

Shanshan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.